Corcept Therapeutics | CORT - Stock


Corcept Therapeutics reported $13.18M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 108.67M 77.1M Jun/2026
ANI Pharmaceuticals USD 143.15M 319K Jun/2026
Ardelyx USD 128.02M 110.29M Mar/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Canopy Growth CAD 110.51M 4.96M Mar/2026
Corcept Therapeutics USD 13.18M 295K Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
J&J USD 15.14B 561M Jun/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
Merck USD 6.21B 272M Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.22B 66M Jun/2026
Novartis USD 6.29B 135M Mar/2026
Omeros USD 712K 266K Sep/2021
Pacira USD 134.57M 15.8M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026
TG Therapeutics USD 147.97M 18.94M Jun/2026